Biomarker Assessment of Venous Thromboembolism in Cancer Patients Receiving Checkpoint Blockade

被引：3
|
作者：
Swaidani, Shadi [1 ,2 ]
Roopkumar, Joanna [3 ]
Jun-Shim, Young [1 ]
Charles, Cathy [1 ]
Paul, Slato [1 ]
Kundu, Suman [1 ]
Funchain, Pauline [3 ]
Rayman, Patricia [2 ]
Pavicic, Paul G. [2 ]
Diaz-Montero, C. Marcela [2 ]
Khorana, Alok A. [3 ]
McCrae, Keith R. [1 ,3 ]
机构：
[1] Cleveland Clin, Cardiovasc & Metab Sci, Cleveland, OH 44106 USA
[2] Cleveland Clin, Inflammat and Immun, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130911
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3648
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy
    Basaran, Derman
    Boerner, Thomas
    Suhner, Jessa
    Sassine, Dib
    Liu, Ying
    Grisham, Rachel N.
    Tew, William P.
    Gardner, Ginger J.
    Zivanovic, Oliver
    Sonoda, Yukio
    Roche, Kara Long
    Chi, Dennis S.
    Abu-Rustum, Nadeem R.
    Soff, Gerald A.
    Jewell, Elizabeth L.
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 36 - 40
  • [32] Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
    Di Nisio, Marcello
    Porreca, Ettore
    Ferrante, Noemi
    Otten, Hans-Martin
    Cuccurullo, Franco
    Rutjes, Anne W. S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (02):
  • [33] Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
    Farge, Dominique
    Trujillo-Santos, Javier
    Debourdeau, Philippe
    Bura-Riviere, Alessandra
    Maria Rodriguez-Beltran, Eva
    Antonio Nieto, Jose
    Luisa Peris, Maria
    Zeltser, David
    Mazzolai, Lucia
    Hij, Adrian
    Monreal, Manuel
    MEDICINE, 2015, 94 (32)
  • [34] Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer
    Garas, Shady N.
    McAlpine, Kristen
    Ross, James
    Carrier, Marc
    Bosse, Dominic
    Yachnin, David
    Mallick, Ranjeeta
    Cagiannos, Ilias
    Morash, Chris
    Breau, Rodney H.
    Lavallee, Luke T.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (08) : 381.e1 - 381.e7
  • [35] Risk of Venous Thromboembolism in Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors
    Attia, Doaa
    Wei, Wei
    Pennell, Nathan A.
    McCrae, Keith R.
    Khorana, Alok A.
    Patil, Pradnya
    BLOOD, 2021, 138
  • [36] Risk assessment of venous thromboembolism in hematological cancer patients: a review
    Chan, Thomas Sau-Yan
    Hwang, Yu Yan
    Tse, Eric
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (05) : 471 - 480
  • [37] Venous thromboembolism in cancer patients: risk assessment, prevention and management
    Tukaye, Deepali N.
    Brink, Heidi
    Baliga, Ragavendra
    FUTURE CARDIOLOGY, 2016, 12 (02) : 221 - 235
  • [38] Bleeding Risk in Thrombocytopenic Cancer Patients with Venous Thromboembolism (VTE) Receiving Anticoagulation
    Pemmaraju, Naresh
    Kroll, Michael H.
    Afshar-Kharghan, Vahid
    Oo, Thein H.
    BLOOD, 2012, 120 (21)
  • [39] Application of thromboelastography parameters for the prediction of venous thromboembolism in cancer patients receiving chemotherapy
    Sukhanov, V. A.
    Petrova, O. Y.
    THROMBOSIS RESEARCH, 2014, 133 : S203 - S203
  • [40] Incidence of venous thromboembolism and prophylaxis use in ambulatory cancer patients receiving chemotherapy
    Panizo, E.
    Lecumberri, R.
    Varea, S.
    Garcia-Mouriz, A.
    Paramo, J. A.
    THROMBOSIS RESEARCH, 2010, 125 : S166 - S166
12345